Fundraising FoxSMBC Venture Capital — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
CADDi builds an AI data platform for the manufacturing industry, alongside a procurement platform for custom (made-to-order) parts, using data and AI to unlock knowledge from the production floor.
Advanced ManufacturingAI & Machine LearningB2B MarketplacesSaaSTokyo, JP
Yushiro Kato(Founder)in加藤 勇志郎(代表取締役CEO・共同創業者)Aditya Sastry(Founder)Aki Kobashi(Founder)Alejandro Castellano(Founder)Kato Yushiro(Founder)
Co-investorsAtomicoCoreline VenturesDCM VenturesGlobal BrainGlobis Capital PartnersMinerva Growth Partners+7 more
PRD Therapeutics is a drug-discovery startup developing first-in-class oral SOAT2-selective inhibitors (PRD compounds derived from pyripyropene A) to regulate lipid metabolism.
BiotechLongevityTokyo, JP
細田 莞爾(代表取締役社長 / President & Co-Founder)供田 洋(社外取締役 / Co-Founder)
Co-investorsJIC Venture Growth InvestmentsJAFCO GroupMizuho Capital
株式会社indent develops writing tools and platforms for authors of novels, manga, scripts, and game scenarios, including the "Nola" writing tool, the "Nola Novel" submission site, an e-book self-publishing service, and the short-story site "Prologue." It also operates a studio connecting authors with companies, offering original-work production, contest operation, and novel/manga commissioned production, primarily in Japan.
Creator EconomyMedia & EntertainmentSaaSTokyo, JP
Yuki Kamagata(代表者 (Representative/CEO))
Co-investorsAPOLLO CAPITALW Inc.Nissay Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.